Skip to main content

Table 2 The cell cycle distribution of HepG2 cells in the low expression group and control group

From: CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)

Group G1 (%) S (%) G2/M (%)
Control group 57.44 ± 1.25 29.92 ± 0.22 11.73 ± 1.97
Low CDCA5 expression group 45.81 ± 3.37 27.37 ± 2.78 27.53 ± 0.58
P value 0.005 0.189 < 0.001